Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
4.48
0.37 (9.00%)
At close: Aug 18, 2025, 3:59 PM
4.32
-3.55%
After-hours: Aug 18, 2025, 07:31 PM EDT
9.00% (1D)
| Bid | 3.16 |
| Market Cap | 26.38M |
| Revenue (ttm) | 14.63M |
| Net Income (ttm) | -11.24M |
| EPS (ttm) | -1.04 |
| PE Ratio (ttm) | -4.31 |
| Forward PE | -6.3 |
| Analyst | Buy |
| Ask | 5.28 |
| Volume | 140,953 |
| Avg. Volume (20D) | 763,309 |
| Open | 4.12 |
| Previous Close | 4.11 |
| Day's Range | 4.01 - 4.53 |
| 52-Week Range | 1.98 - 7.95 |
| Beta | 7.00 |
About VVOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VVOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VVOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Vivos Therapeutics Inc. is scheduled to release its earnings on
Aug 29, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
-10.85%
Vivos Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
1 month ago
+22.47%
Vivos Therapeutics shares are trading higher after the company received Medicare approval for its VidaSleep oral appliance.
3 months ago · seekingalpha.com
Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call TranscriptVivos Therapeutics, Inc. (NASDAQ:VVOS ) Q1 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Brad Amman - CFO Kirk Huntsman - Chairman and CEO Conference Call Participants Do ...
